Internal Medicine, Infectious Disease · Gainesville, GA
NPI
1366670051
Since 2009
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
10
Medicare group memberships
Hospitals
3
Hospital affiliations
743 Spring St NE
Gainesville, GA, 30501
Phone (770) 219-9000
Groups this clinician bills Medicare through
Medicare paid, 2024
$89K
1,250 services
Medicare patients, 2024
477
Average age 74
Drug cost, 2024
$1.5M
2,285 prescriptions
Company payments, 2025
$477
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Budder Siddiqui was code 99214 (office e&m - established), 305 times for 191 patients. In total Budder Siddiqui billed 1,250 services in 21 codes, and Medicare paid $89K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 305 | 191 | $90.68 | $28K |
| 99213 Office E&M - Established | Office | 217 | 151 | $63.78 | $14K |
| 36415 Venipuncture Blood Collection | Office | 200 | 127 | $8.65 | $1,730 |
| 99204 Office E&M - New | Office | 88 | 88 | $112.27 | $9,880 |
| 99215 Office E&M - Established | Office | 72 | 55 | $132.69 | $9,554 |
| 99222 Hospital E&M - Initial | Facility | 54 | 54 | $98.28 | $5,307 |
| 99443 Telephone Services | Office | 54 | 37 | $93.07 | $5,026 |
| 99232 Hospital E&M - Subsequent | Facility | 52 | 37 | $53.45 | $2,779 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 46 | 32 | $12.16 | $559 |
| 99212 Office E&M - Established | Office | 35 | 35 | $38.04 | $1,331 |
| 99442 Telephone Services | Office | 28 | 25 | $62.85 | $1,760 |
| 99203 Office E&M - New | Office | 28 | 28 | $82.80 | $2,318 |
| 99291 Critical Care E&M | Facility | 15 | 11 | $123.85 | $1,858 |
| 99205 Office E&M - New | Office | 15 | 15 | $164.97 | $2,475 |
| 99233 Hospital E&M - Subsequent | Facility | 14 | 13 | $88.43 | $1,238 |
By year: 2022 $39K for 522 services; 2023 $83K for 1,147 services; 2024 $89K for 1,250 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 200 | 127 | $8.65 | $1,730 |
Medicare prescription drug claims, 2024
In 2024, the drug Budder Siddiqui prescribed most often to Medicare patients was Cephalexin, with 193 prescriptions and refills. In total Budder Siddiqui wrote 2,285 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cephalexin Generic | 193 | 228 | 97 | $2,760 |
| Fluconazole Generic | 148 | 152 | 60 | $6,510 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 133 | 143 | 78 | $1,789 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 119 | 126 | 15 | $504K |
| Ciprofloxacin Hcl Generic | 100 | 108 | 59 | $1,375 |
| Ondansetron Odt Ondansetron | 99 | 100 | 71 | $2,023 |
| Linezolid Generic | 88 | 96 | 49 | $9,592 |
| Azithromycin Generic | 83 | 102 | 24 | $1,359 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 81 | 106 | 43 | $652 |
| Cefepime Hcl Generic | 75 | 75 | 19 | $26K |
| Doxycycline Hyclate Generic | 69 | 91 | 36 | $1,318 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 67 | 68 | 41 | $1,109 |
| Ethambutol Hcl Generic | 55 | 62 | 13 | $1,350 |
| Ertapenem Ertapenem Sodium | 54 | 54 | 18 | $33K |
| Amoxicillin Generic | 54 | 89 | 20 | $651 |
Brand drugs: 345 claims; generic drugs: 1,940 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Budder Siddiqui $477 ($477 in general payments such as food, travel and fees) from 11 companies. The largest payer was ViiV Healthcare Company with $137.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 5 | $137 |
| Insmed, Inc. INSM | 4 | $93.43 |
| Gilead Sciences, Inc. GILD | 2 | $57.82 |
| Abbvie Inc. ABBV | 2 | $43.74 |
| Shionogi Inc 4507.T | 1 | $30.76 |
| Napo Pharmaceuticals Inc | 1 | $26.59 |
| Aimmune Therapeutics, Inc. | 1 | $20.78 |
| Cumberland Pharmaceuticals, Inc. CPIX | 1 | $18.37 |
| Melinta Therapeutics, LLC | 1 | $16.55 |
| Astellas Pharma US Inc 4503.T | 1 | $16.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.